Security Snapshot

Fresenius Medical Care AG - Ordinary Shares without par value (FMS) Institutional Ownership

CUSIP: 358029106

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

210

Shares (Excl. Options)

37,498,973

Price

$23.82

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Create free account to save this page Review latest holder period
Type / Class
Equity / Ordinary Shares without par value
Symbol
FMS on NYSE
Shares outstanding
292,938,399
Price per share
$23.61
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
37,498,973
Total reported value
$893,223,505
% of total 13F portfolios
0%
Share change
+1,412,812
Value change
+$33,311,910
Number of holders
210
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • FMS - Fresenius Medical Care AG - Ordinary Shares without par value is tracked under CUSIP 358029106.
  • 210 institutions reported positions in Q4 2025.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 210 to 71 between Q4 2025 and Q1 2026.
  • Reported value moved from $893,223,505 to $372,521,313.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 210 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 358029106?
CUSIP 358029106 identifies FMS - Fresenius Medical Care AG - Ordinary Shares without par value in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Fresenius Medical Care AG - Ordinary Shares without par value (FMS) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Fresenius SE & Co. KGaA 29% -11% $2,024,971,833 -$256,202,000 83,780,382 -11% Fresenius SE & Co. KGaA 06 Mar 2025
HARRIS ASSOCIATES L P 3.9% $283,213,788 11,717,575 HARRIS ASSOCIATES L P 31 Dec 2024

As of 31 Dec 2025, 210 institutional investors reported holding 37,498,973 shares of Fresenius Medical Care AG - Ordinary Shares without par value (FMS). This represents 13% of the company’s total 292,938,399 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Fresenius Medical Care AG - Ordinary Shares without par value (FMS) together control 12% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
PZENA INVESTMENT MANAGEMENT LLC 5% 14,752,836 -0.43% 1.1% $351,412,563
FIDUCIARY MANAGEMENT INC /WI/ 1.7% 4,961,969 -9.1% 1.3% $118,194,102
Dodge & Cox 1.3% 3,826,910 0% 0.05% $91,156,996
MORGAN STANLEY 1% 2,939,838 +47% 0% $70,026,979
TODD ASSET MANAGEMENT LLC 0.44% 1,286,763 -1.3% 0.6% $30,650,843
Point72 Asset Management, L.P. 0.39% 1,132,814 +112% 0.04% $26,983,629
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY 0.28% 816,200 0% 0.15% $19,442,000
GOLDMAN SACHS GROUP INC 0.25% 735,014 -5.7% 0% $17,508,030
Integral Health Asset Management, LLC 0.22% 650,000 +44% 0.78% $15,483,000
BlackRock, Inc. 0.16% 461,759 -1.4% 0% $10,999,105
NORTHERN TRUST CORP 0.14% 401,076 -4% 0% $9,553,631
HENNESSY ADVISORS INC 0.12% 349,500 -6.1% 0.3% $8,325,090
Quantinno Capital Management LP 0.1% 294,915 +24% 0.01% $7,024,894
RAYMOND JAMES FINANCIAL INC 0.1% 286,898 +1.7% 0% $6,833,913
Moran Wealth Management, LLC 0.09% 264,462 +67% 0.19% $6,299,485
ENVESTNET ASSET MANAGEMENT INC 0.09% 255,716 -8.7% 0% $6,091,155
ABC ARBITRAGE SA 0.09% 249,800 +1136% 0.56% $5,950,236
Qube Research & Technologies Ltd 0.07% 201,872 -9.6% 0.01% $4,808,591
NIA IMPACT ADVISORS, LLC 0.05% 152,962 -6.5% 1.2% $3,643,558
JANE STREET GROUP, LLC 0.05% 135,434 +200% 0% $3,226,038
FMR LLC 0.05% 134,693 -13% 0% $3,208,395
UBS Group AG 0.03% 101,827 -34% 0% $2,425,519
JPMORGAN CHASE & CO 0.03% 98,901 +76% 0% $2,355,824
XTX Topco Ltd 0.03% 94,093 +743% 0.06% $2,241,295
BANK OF AMERICA CORP /DE/ 0.03% 83,089 +1.1% 0% $1,979,180

Institutional Holders of Fresenius Medical Care AG - Ordinary Shares without par value (FMS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 16,512,463 $372,521,313 +$15,187,105 $22.56 71
2025 Q4 37,498,973 $893,223,505 +$33,311,910 $23.82 210
2025 Q3 36,120,634 $951,005,129 -$14,569,100 $26.33 203
2025 Q2 36,636,431 $1,046,674,202 +$46,295,068 $28.57 203
2025 Q1 35,046,889 $872,643,678 +$27,257,295 $24.90 197
2024 Q4 34,017,350 $770,139,012 +$5,191,746 $22.64 187
2024 Q3 33,465,497 $713,210,489 +$46,953,355 $21.30 164
2024 Q2 31,332,670 $598,145,446 -$36,538,124 $19.09 166
2024 Q1 33,213,535 $640,484,181 -$410,800 $19.28 168
2023 Q4 33,129,394 $689,882,206 -$1,429,220 $20.83 160
2023 Q3 33,054,027 $711,494,307 -$24,576,102 $21.54 146
2023 Q2 34,074,546 $815,697,393 -$113,386,403 $23.93 141
2023 Q1 38,943,140 $828,079,836 -$106,128,012 $21.26 147
2022 Q4 44,147,684 $721,518,359 +$190,854,706 $16.34 151
2022 Q3 32,612,977 $457,762,115 -$40,450,898 $14.04 133
2022 Q2 32,237,246 $803,829,195 +$52,339,396 $24.94 155
2022 Q1 30,584,664 $1,030,101,462 +$97,919,185 $33.68 173
2021 Q4 27,697,563 $899,187,170 +$54,237,214 $32.46 165
2021 Q3 25,876,821 $905,133,412 +$190,668,853 $34.97 150
2021 Q2 20,356,867 $846,033,789 +$44,454,274 $41.57 168
2021 Q1 19,343,763 $713,592,444 +$321,140,390 $36.88 162
2020 Q4 10,477,415 $435,514,087 +$61,869,042 $41.56 169
2020 Q3 9,057,592 $384,729,746 +$298,263 $42.48 175
2020 Q2 9,267,915 $401,447,759 +$17,538,666 $43.28 170
2020 Q1 8,974,855 $294,569,245 -$29,833,385 $32.80 164
2019 Q4 9,680,491 $356,666,606 +$46,131,193 $36.83 158
2019 Q3 8,489,300 $285,105,242 -$16,844,569 $33.59 151
2019 Q2 8,950,197 $351,529,404 -$460,985 $39.28 162
2019 Q1 8,941,080 $362,331,240 -$95,805,052 $40.53 174
2018 Q4 11,388,563 $369,019,549 -$138,129,963 $32.39 180
2018 Q3 14,718,338 $756,764,850 -$5,906,145 $51.42 211
2018 Q2 15,162,171 $763,413,834 -$7,227,748 $50.35 218
2018 Q1 15,297,396 $781,593,438 +$24,203,270 $51.08 225
2017 Q4 14,819,242 $778,776,107 -$202,631,503 $52.55 216
2017 Q3 18,646,855 $911,697,869 +$129,634,957 $48.89 202
2017 Q2 16,003,620 $773,467,989 -$22,236,435 $48.33 187
2017 Q1 16,530,566 $696,655,793 +$35,942,277 $42.13 182
2016 Q4 15,727,940 $663,668,094 +$4,815,697 $42.21 181
2016 Q3 15,540,077 $680,561,144 +$53,327,989 $43.77 178
2016 Q2 14,264,054 $621,723,704 +$22,300,933 $43.57 168
2016 Q1 13,795,412 $607,780,798 +$162,209,272 $44.08 170
2015 Q4 10,134,777 $423,471,816 -$43,799,011 $41.84 145
2015 Q3 11,220,499 $438,080,897 +$5,290,906 $39.01 136
2015 Q2 11,398,223 $474,110,703 -$15,390,530 $41.59 139
2015 Q1 11,780,877 $488,479,999 -$12,986,545 $41.45 137
2014 Q4 12,202,625 $453,352,333 -$28,432,090 $37.14 139
2014 Q3 12,932,041 $449,021,219 -$22,303,536 $34.70 125
2014 Q2 13,519,503 $452,998,292 -$29,506,824 $33.49 130
2014 Q1 14,370,640 $500,971,845 -$59,867,800 $34.85 125
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .